Azathioprine
Treatment for Inflammatory bowel disease
Typical Dosage: 2.0-2.5 mg/kg daily
Effectiveness
62%
Safety Score
35%
Clinical Trials
81
Participants
15K
Comparative Safety Scale(Higher is safer)
Cyanide☠️
Meth💀
Cigarettes🚬
Chemo☢️
Alcohol🍺
Morphine💊
Antibiotics💉
Tylenol💊
Exercise🏃
Water💧
35
DangerousModerateSafe
Treatment Details
Dosage Range
2.0-2.5 mg/kg daily
Time to Effect
3-6 months
Treatment Duration
years
Evidence Quality
HIGHNumber Needed to Treat (NNT)
5(Treat 5 patients to see 1 additional successful outcome)
Number Needed to Harm (NNH)
20(Treat 20 patients to see 1 additional serious adverse event)
Confidence Score
85%confidence in effectiveness data
Health Economics
Annual Cost of Care
Drug Cost:$200
Monitoring:$1,300
Side Effect Mgmt:$500
Total Annual:$2,000
Cost-Effectiveness Analysis
Cost-Effectiveness Rating
GOODICER
$80,000/QALY
QALYs Gained
0.15
Outcome-Based Costs
Cost per Responder
$4,444
Cost per Remission
$8,000
WARNING: LIMITED TRIALS AVAILABLE
You can search for trials, but you probably can't join any because the 1% Treaty hasn't passed yet. Most trials are severely limited by lack of funding and bureaucratic barriers. Help change this!
Active Clinical Trials
2 active trials recruiting for Azathioprine in Inflammatory bowel disease
Medical Treatment Versus Surgery in Stricturing Small Bowel Crohn's Disease
NCT05584228NOT YET RECRUITINGNA
150 participants
INTERVENTIONAL
Started: Apr 1, 2023
HLADQA1*05 Genotype and the Efficacy of Treatment With Infliximab in Chinese Population Crohn's Disease
NCT05813860NOT YET RECRUITINGPHASE4
976 participants
INTERVENTIONAL
Started: Apr 30, 2023
Completed Clinical Trials
8 completed trials for Azathioprine in Inflammatory bowel disease
Azathioprine & Allopurinol in Inflammatory Bowel Disease Patients
NCT00849368COMPLETEDPHASE1
6 participants
INTERVENTIONAL
Zurich, Switzerland
Started: Jan 1, 2009
Abdominal Ultrasound With Doppler and Peripheral Hemogram in Assesment Inflammatory Bowel Disease
NCT03445624COMPLETED
60 participants
OBSERVATIONAL
Asyut, Egypt
Started: Jul 1, 2018
Azathioprine Linked With Impaired Intestinal Epithelial Postoperative Regeneration in Crohn's Disease
NCT05456776COMPLETED
35 participants
OBSERVATIONAL
Started: Apr 1, 2014
Chronotherapy in Inflammatory Bowel Disease
NCT04304950COMPLETEDPHASE4
28 participants
INTERVENTIONAL
Chicago, United States
Started: Apr 25, 2016
Efficacy of LiveSpo COLON as a Supportive Treatment for Inflammatory Bowel Disease (IBD)
NCT06637683COMPLETEDNA
60 participants
INTERVENTIONAL
Thái Bình, Vietnam
Started: Nov 15, 2019
Preventing Postoperative Relapse in Crohn's Disease Patients at Risk: Azathioprine Versus Mesalazine
NCT00946946COMPLETEDPHASE3
78 participants
INTERVENTIONAL
Vienna, Austria +1 more
Started: Feb 1, 2002
Immunogenicity of Influenza, Pneumococcal and Hepatitis B Vaccines in IBD Patients Treated With Vedolizumab
NCT03056924COMPLETED
173 participants
OBSERVATIONAL
Boston, United States
Started: Jul 5, 2017
Cost-effectiveness of TPMT Pharmacogenetics
NCT00521950COMPLETEDNA
853 participants
INTERVENTIONAL
Nijmegen, Netherlands +2 more
Started: Sep 1, 2007
Showing 20 of 85 total trials